Only a few companies can now afford to build and study the most advanced AI models. That has big implications for independent ...
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced several executive transitions and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback